Chronic Rhinosinusitis Trial, Recruiting (NCT05938972)

Chronic Rhinosinusitis Trial, Recruiting NCT05938972 Sponsor: University Hospital, Ghent Condition: Chronic Rhinosinusitis

Printed from Voxsanity (voxsanity.com.au) — NCT05938972 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Chronic Rhinosinusitis

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You must be willing and able to sign a consent form agreeing to take part in the study
You must be between 18 and 80 years old at the time of signing the consent form
You must be able to follow the study's rules and requirements, as judged by the study doctor
(Group 1) You have severe allergic and/or eosinophilic asthma and are either already receiving a biological medicine as part of your standard treatment, or are about to start one
(Group 2) You have chronic sinusitis with nasal polyps (with or without asthma), are about to start a biological medicine as part of your standard treatment, and meet the official criteria to have that biological medicine covered/reimbursed

Who may not be able to join:

If you do not meet the official criteria required for your biological medicine to be covered or reimbursed, you would not be eligible to participate in this study

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 28 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Philippe Gevaert, Prof. Dr., University Hospital, Ghent

Phone: +32 09 332 23 98

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT05938972

Sponsor: University Hospital, Ghent

Phase: Not Applicable

Status: Recruiting

Condition: Chronic Rhinosinusitis

Trial contact: +32 09 332 23 98

More information: https://clinicaltrials.gov/study/NCT05938972

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You must be willing and able to sign a consent form agreeing to take part in the study
You must be between 18 and 80 years old at the time of signing the consent form
You must be able to follow the study's rules and requirements, as judged by the study doctor
(Group 1) You have severe allergic and/or eosinophilic asthma and are either already receiving a biological medicine as part of your standard treatment, or are about to start one
(Group 2) You have chronic sinusitis with nasal polyps (with or without asthma), are about to start a biological medicine as part of your standard treatment, and meet the official criteria to have that biological medicine covered/reimbursed

Who may not be able to join:

If you do not meet the official criteria required for your biological medicine to be covered or reimbursed, you would not be eligible to participate in this study

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 28 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

University Hospital, Ghent

Registry

ClinicalTrials.gov

Start date

1 March 2022

Est. completion

31 December 2030

Where this trial is recruiting

🇧🇪 Belgium

Primary endpoints

Clinical characteristics; Clinical characeristics; Local nasal immunity

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov